drugset / Trial / NCT03574337

Residual Neuromuscular Blockade in Cardiac Surgery Patients

NCT03574337 ↗

Phase 4 Withdrawn Henry Ford Health System
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

The purpose of this project is to determine if reversal of neuromuscular blockade in cardiac surgery patients expedites time to extubation in fast track patients.

Timeline

Start
2018-08-01
Primary completion
2018-08-30
Completion
2018-08-30

Outcome

Outcome not reported

Stopped (Business): “Inadequate funding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glycopyrrolate Small molecule — —
Comparator Neostigmine Other / unclassified 50 ug/kg —
Comparator Sugammadex Other / unclassified — —